tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Aschoff, 117 are a BUY (89.31%), 7 are a HOLD (5.34%), 7 are a SELL (5.34%).
Analyst Jonathan Aschoff, currently employed at ROTH MKM, carries an average stock price target met ratio of 34.54% that have a potential upside of 35.75% achieved within 129 days. Previously, Jonathan Aschoff worked at BREAN.
Jonathan Aschoff’s has documented 235 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Energy, Consumer Cyclical sectors.
Most recent stock forecast was given on CLRB, Cellectar Biosciences at 05-May-2026.
Analyst best performing recommendations are on PBLA (PANBELA THERAPEUTICS).
The best stock recommendation documented was for PBLA (PANBELA THERAPEUTICS) at 12/18/2023. The price target of $25 was fulfilled within 1 day with a profit of $4.8 (23.76%) receiving and performance score of 237.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 5 months 17 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 5 months 19 days ago
(03-May-2021)
17/29 (58.62%)
$2.73 (1.60%)
650
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 5 months 26 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 8 months 18 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 17-Jul-2017
$166
$-16.5 (-9.04%)
$175
5 years 8 months 18 days ago
(04-Feb-2021)
32/33 (96.97%)
$10.41 (6.69%)
867
Which stock is Jonathan Aschoff most bullish on?
What Year was the first public recommendation made by Jonathan Aschoff?
